# Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer

> **NCT03067610** · PHASE2 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 72 (actual)

## Conditions studied

- Head and Neck Cancer
- Carcinoma, Squamous Cell
- Neoplasms, Oral
- Neoplasms, Pharyngeal

## Interventions

- **RADIATION:** Intensity Modulated Radiation Therapy
- **DRUG:** chemotherapy

## Key facts

- **NCT ID:** NCT03067610
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-20
- **Primary completion:** 2020-12-21
- **Final completion:** 2021-03-09
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03067610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03067610, "Involved Field Elective Volume De-Intensification Radiation Therapy for Head and Neck Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03067610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*